ITM Obtains Up to $262.5 Million in Non-Dilutive Debt Financing from Blue Owl Managed Funds
ITM Secures Up to $262.5m in Non-dilutive Debt Financing with Blue Owl Managed Funds ITM Isotope Technologies Munich SE Debt capital to support commercial readiness and potential U.S. launch of n.c.a. 177Lu-edotreotide (ITM-11), following positive Phase 3 results Flexible funding structure enables continued advancement of ITM’s targeted radiopharmaceutical pipeline and leading radioisotope manufacturing business Garching / […]